DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Faropenem
Faropenem
Download
Dose Amoxicillin/Clavulanate
Consideration of Antibacterial Medicines As Part Of
WO 2010/025328 Al
Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R
Comparison of Effectiveness and Safety of Imipenem/Clavulanate- Versus Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- and XDR-TB
Ige and Drug Allergy: Antibody Recognition of 'Small' Molecules of Widely Varying Structures and Activities
Novel Drug Targets for Food-Borne Pathogen Campylobacter Jejuni: an Integrated Subtractive Genomics and Comparative Metabolic Pathway Study
Emerging Modalities to Combat Resistant Gram-Negative Pathogens in Critically Ill Patients: Part 2: Focus on the Carbapenems
Gaps in Knowledge in Therapeutics and Treatment
(12) United States Patent (10) Patent No.: US 9,347,888 B2 Ghirardi Et Al
Possible Factors Involved in Oral Inactivity of Meropenem, a Carbapenem Antibiotic
APPLICATION of STRUCTURE ACTIVITY RELATIONSHIPS of the MYCOBACTERIUM TUBERCULOSIS BETA-LACTAMASE (Blac)
Reinvigorating the Oral Antibacterial Drug Development Pipeline Slide Deck
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Harnessing Β-Lactam Antibiotics for Illumination of the Activity of Penicillin-Binding Proteins
Precautions Interactions Antimicrobial Action Pharmacokinetics Uses And
Current Treatment of Community-Acquired Pneumonia
Top View
Essential Medicines List Covers Anti-Infective Medicines
NICE Guideline. Urinary Tract Infection (Lower): Antimicrobial Prescribing
2019 Antibacterial Agents in Clinical Development
Successful Use of Repurposed Drugs for MDR TB: Meropenem/Clavulanate and Its Newer Rela Ves
Comparative Stability Studies of Antipseudomonal -Lactams For
Current Status in Outpatient Parenteral Antimicrobial Therapy: a Practical View
BSAC Standardized Disc Susceptibility Testing Method
Risk of Hypoglycemia Induced by Pivalate-Conjugated Antibiotics in Young Children: A
Treatment Guidelines for Antimicrobial Use in Common Syndromes 2019
The in Vitro Effects of Faropenem on Lower Respiratory Tract Pathogens Isolated in the United Kingdom
Beta-Lactams for MDRGPC?
Experience of Faropenem for the Management of Urinary Tract Infection: Real-World Experience from India
Faropenem Resistance Causes in Vitro Cross-Resistance to Carbapenems in ESBL-Producing Escherichia Coli
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Impact of ABSSSI in U.S
Mycobacterial Cell Wall: a Source of Successful Targets for Old and New Drugs
The Challenge of Drug Resistant Tuberculosis
Emergence of Polymyxin B As a Viable
ANTIBIOTIC DEVELOPMENT for RESISTANT BACTERIA a Pharmacometric-Based Solution
Supplementary
Fenemor 200: Each Film Coated Tablet Contains Faropenem Sodium 200 Mg
Bad Bugs, No Drugs: No ESKAPE! an Update from the Infectious Diseases Society of America
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Genetic Analysis of Faropenem-Resistant Enterococcus Faecalis in Urinary Isolates Noriyuki Hiraga, Tetsuro Muratani, Seiji Naito, Tetsuro Matsumoto
Categorisation of Antibiotics for Use in Animals EMA for Prudent and Responsible Use
Mycobacterium Tuberculosis Penicillin-Binding Protein 3 in Complex with Five B-Lactam Antibiotics Reveal Mechanism of Inactivation S
Update on Acute Bacterial Rhinosinusitis